ACET compared with PRLD: revenue, margins and what each company keeps, and the suppliers and customers both name

ACETAdicet Bio, Inc.

Mkt capRevenueRevenue

PRLDPrelude Therapeutics Inc

Mkt capRevenueRevenue

Compare

ACETAdicet Bio, Inc.

PRLDPrelude Therapeutics Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

ACET: latest quarter not drawable. PRLD: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

ACET, solidPRLD, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ACET 4

REGNRegeneronsupplier

TWSTTwist Biosciencesupplier

CRSPCRISPR Therapeuticssupplier

—City of Hopeunlistedsupplier

Shared 0

No shared counterparties.

Only PRLD 3

INCYIncytecustomer

ABCLAbCellera Biologicscustomer

—Pathos AIunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

ACETAdicet Bio, Inc.

3.41· pre 3.42

Mkt cap$32.0MRevenue—

PRLDPrelude Therapeutics Inc

3.89· pre 3.89· delayed

Pre-marketSep 2 '83

Mkt cap$309.6MRevenue$6MQ2 FY26

Compare

Pre-marketSep 2 '83

ACETAdicet Bio, Inc.

PRLDPrelude Therapeutics Inc

3.41pre 3.42

Price

3.89pre 3.89delayed

$32.0M

Mkt cap

$309.6M

—

Revenue

$6MQ2 FY26

ACET3.41vsPRLD3.89Pre-marketSep 2 '83